US 6,897,015 B2Grant

Device and method of use for detection and characterization of pathogens and biological materials

Issue Date:2005-05-24

•40 Claims

•8 Drawing Sheets

Abstract

The present invention includes a method and apparatus for the detection of a target material. The method and apparatus includes providing a substrate with a surface and forming a domains of deposited materials thereon. The deposited material can be placed on the surface and bound directly and non-specifically to the surface, or it may be specifically or non-specifically bound to the surface. The deposited material has an affinity for a specific target material. The domains thus created are termed affinity domains or deposition domains. Multiple affinity domains of deposited materials can be deposited on a single surface, creating a plurality of specific binding affinity domains for a plurality of target materials. Target materials may include, for example, pathogens or pathogenic markers such as viruses, bacteria, bacterial spores, parasites, prions, fungi, mold or pollen spores. The device thus created is incubated with a test solution, gas or other supporting environment suspected of containing one or more of the target materials. Specific binding interactions between the target materials and a particular affinity domain occurs and is detected by various methods.

Metadata

Assignee

BioForce Nanosciences, Inc.

Inventors

Eric R. Henderson
Saju R. Nettikadan
Curtis L. Mosher

Application Information

Application Number:US 10/160,372

Filing Date:2002-05-30

Priority Date:2000-03-07

Art Unit:1631

Patent Drawings (8 sheets)

Description

Cross-Reference to Related Application(s)

[0001] This application is a CIP of U.S. application Ser. No. 09/519,271, filed Mar. 7, 2000, U.S. Pat. No. 6,716,578 and is a CIP of U.S. application Ser. No. 09/574,519, filed May 18, 2000, U.S. Pat. No. 6,573,369.

Field of the Invention

[0002] The present invention relates to the detection and characterization of pathogens, viruses, and other biological materials.

Background of the Invention

[0003] Pathogens constitute a critical problem for human, animal and plant health. Pathogens may cause infections that result in a variety of human illnesses and can lead to a large number of deaths. Such pathogens may include viruses, bacteria, prions, fungi, molds, eukaryotic microbes and parasites of many types. Moreover, pathogens infect agriculturally important plant and animal species, resulting in economic hardship. Detection and identification of pathogens in relevant materials (e.g., water, air, blood, tissues, organs, etc.) is essential to minimize the transfer and spread of infections. Furthermore, quick identification may aid in devising effective treatment strategies.

[0004] One class of pathogens is viruses. Viruses are used here as an example and not intended to limit the scope of the invention in any way. Viral infections extol a great morbidity and mortality among the human population. Many of these infections result from undetected viruses in waters, foods and air and are promulgated by an ever-increasing interconnection of societies. Detection and identification in medically-important materials such as blood, blood derivatives, tissues and organs is critical to minimize potentials for transfer and spread within hospitals and clinics and to the staff of these centers.

[0005] Several popular methods for the detection and identification of viruses and pathogens exist. These generally fall into three categories: A) Infectivity and infectivity reduction assays; B) Serology assays employing antibody detection to determine whether an individual has been exposed; and C) Direct virology assays in which antibodies are used to detect the presence of an antigen in the sample or nucleic acid-based assays in which elements of the viral genome are detected. Infectivity-based assays are seldom used in diagnostics yet, both cell culture and animal-based amplification of virus in a sample may be necessary for many of the current diagnostic procedures. The use of animals in infectivity assays is costly, time consuming and subject to ethical dispute. Serodiagnosis still exists in many-hospitals principally because there are no good alternatives for some infections. Serology is largely performed to determine antibody levels and to estimate the probability for infection. Antibody based tests are popular, but are usually limited to a battery of individual tests in a macroscopic format (e.g., Enzyme Linked ImmunoSorbant Assay, or ELISA). Standard microbiological approaches to detect anthrax and other bacterial pathogens involve growth of the agent on nutrient agar and visual identification after various staining procedures. Carbon source utilization testing in various media identifies and differentiates among closely related isolates. Viral pathogens are usually identified after their administration, infection and amplification in animals, particularly embryonated eggs, mice or cell culture. This is the basic microbial identification scheme practiced today. While precise in their verification of pathogen identity, these procedures are very slow.

[0006] False-positives and false-negatives, particularly in cases where there is known cross reaction with antigens produced by other infections, are of major importance. Polymerase chain reaction (PCR) tests are extremely sensitive and are usually employed in cases where there is prior reason to suspect the presence of a particular pathogen, such as following a positive test for HIV antigens. PCR methods, however, are relatively costly and time consuming. Furthermore, PCR tests are of a relatively limited applicability because of the requirement of enzyme activity and because of the frequency of false positives.

Brief Summary of the Invention

[0007] The invention described herein is an affinity capture substrate, or sensor, that can be read by an atomic force microscope (AFM) or another type of scanning probe microscope (SPM) for a simple, rapid, sensitive and high throughput method for detection of pathogens, biological materials, viruses, etc. This method can be applied to detect the target material in a target sample, including whole viruses, viral proteins and viral nucleic acids as well as to distinguish between strains of similar pathogens and biomaterials. Additionally, fluorescence or other methods commonly practiced for detection of biological binding events can be employed when desired.

[0008] A method of detecting a target pathogen, comprising the steps of providing a substrate with a surface, depositing a patterned gold layer on the surface, depositing a deposition material on the surface, the deposition material capable of interacting with the target pathogen, and exposing the deposition material to a target sample which can contain the target pathogen and detecting resultant molecular interaction events between the deposition material and the target pathogen by imaging the surface with an atomic force microscope.

[0009] An apparatus for the detection of a vaccinia virus, comprising a gold layer deposited on a substrate, an C(x) alkane linker covalently attached to the gold layer, protein A/G tethered to the surface through the alkane linker, and anti-vaccinia antibody deposited on the surface in a domain such that a portion of the deposited antibody retains activity.

[0010] A method of detecting a target pathogen, comprising the steps of providing a substrate with a surface, depositing a deposition material on the surface, the deposition material capable of interacting with the target pathogen, exposing the deposition material to a target sample which can contain the target pathogen and detecting resultant molecular interaction events between the deposition material and a target pathogen.

Brief Description of the Drawings

[0011] FIG. 1 is an illustration of the AFM detection method.

[0012] FIG. 2a is a graphical representation of a chip with a deposition material thereon and an AFM scan of the same.

[0013] FIG. 2b is a graphical representation of a chip with a deposition material on the surface that has a target material attached and an AFM scan of the same.

[0014] FIG. 3 is a graphical representation of a chip with two different deposition materials placed onto two different deposition domains.

[0015] FIG. 4a is a graphical representation of a chip with a deposition material on the surface and a control surface before and after attachment of a target material.

[0016] FIG. 4b is another graphical representation of the chip of FIG. 4a.

[0017] FIG. 4c is a representation of an AFM scan of the chip of FIG. 4a.

[0018] FIG. 5a illustrates the representative layers of a chip where a deposition material is attached by passive adsorption.

[0019] FIG. 5b illustrates the representative layers of a chip where a deposition material is attached by active immobilization.

[0020] FIG. 6a is a perspective view of a chip of the present invention with deposition material deposited thereon.

[0021] FIG. 6b is a perspective view of a chip of the present invention after being exposed to a target sample containing a target material.

[0022] FIG. 6c is a perspective view of the chip of FIG. 6b after washing.

[0023] FIG. 7a is an AFM scan of a chip of the present invention after deposition of a deposition material.

[0024] FIG. 7b is a scan of the chip of FIG. 7a after exposing the chip to a target material.

[0025] FIG. 7c is a scan of a chip of the present invention after exposing the chip to a control.

[0026] FIG. 8 is a graph of the number of target material particles bound to a chip surface versus exposure time for various concentrations of target material.

Detailed Description

[0027] Definitions

[0028] The following are some definitions that may be helpful in understanding the description of the present invention. These are intended as general definitions and are put forth for a better understanding of the below description but should in no way limit the scope of the present invention.

[0029] As used herein the term “pathogen” is used to mean any sort of viral, bacterial, fungal, prion, microbial or other material that can be detected using the teachings of the present invention. The term “pathogen” as used herein can be natural biological agents or artificial materials. Pathogens may include, for example, but not limited to, viruses, eukaryotic microbes, bacteria, fungi, parasites and prions. In particular, pathogens can be a canine parvovirus of the parvoviridae family or a vaccinia virus of the poxviridae family.

[0030] The term “target material” is the pathogen that is to be detected.

[0031] The term “target sample” is a substance that is being tested to determine whether the target material is contained therein. These target samples can be natural or man-made substances. Alternatively the target sample may be a biologically produced product or an artificially made product. The target samples may be a solution, gas, or other medium.

[0032] The term “deposition material” or “deposited material” is the material deposited on the chip for which the target material has some known affinity, such as a binding agent. The deposition material can be deposited in a deposition domain, otherwise known as an affinity domain. The deposition material and the target material can undergo a non-specific binding event, such as, but not limited to, non-specific electrostatic or hydrophobic interactions, or a specific molecular interaction event, such as covalent or ionic attachment. Such deposition materials can include, but are not limited to antibodies, proteins, peptides, nucleic acids, peptide aptamers, or nucleic acid aptamers. In the below described embodiments, the deposited materials are antibodies to known viral pathogens. Antibodies are proteins that bind specifically to a target.

[0033] The term “chip” as used in the present invention includes a substrate that has a surface. The “chip” may or may not include the deposition material deposited thereon. Afterwards, the chip is exposed to the target sample to detect the target material.

[0034] The present example illustrates the detection of viruses as the target material. The deposition material is the corresponding antibody. The antibody is a naturally occurring or synthetic protein that binds specifically to the target. In the present examples, Canine parvovirus (CPV) and vaccinia virus were detected.

[0035] CPV belongs to the Parvoviridae family of viruses and is among the smallest viruses known. Parvoviruses are among simplest eukaryotic viruses and were only discovered in the 1960's. Parvoviral particles are icosahedral, 18-26 nm in diameter and consist of protein (50%) and DNA (50%). The virions are not enveloped and the nucleocapsid confers considerable stability to the particles. There are three capsid proteins, VP1, VP2 and VP3. Infectious virions of CPV contain 60 protein subunits, predominantly VP2.

[0036] Vaccinia virus belongs to the poxvirus family and is among the largest viruses known. The vaccinia virus is an analog of smallpox, a designated biowarfare material. Furthermore, the vaccinia viruses are the largest of the DNA viruses affecting humans. The vaccinia virus is enveloped; slightly pleomorphic; ovoid, or brick-shaped. The viral particles are 140-260 nm in diameter and around 220-450 m long. The viral particle is composed of an external coat containing lipid and tubular or globular protein structures enclosing one or two lateral bodies and a core, which contains the genome. Nucleocapsids are brick-shaped to ovoid. The core is usually biconcave with two lateral bodies.

[0037] To form a chip that comports with the teachings of the present invention, a substrate must first be prepared. Substrates were prepared using #1 glass cover slips (Fisher Scientific) that were cut into 7 mm×7 mm squares and cleaned thoroughly for 30 min in ethanol using an ultrasonic bath. The glass substrates can be stored in ethanol until ready for use. The glass substrates were then coated with a thin layer (˜3 nm) of chromium at 0.1 nm/s followed by the deposition of 20 nm gold at 0.2 nm/sec using an IBC 2000 (South Bay Technologies). The surface was patterned by placing a copper electron microscopy grid (400 mesh, hole size 100 um, bar size 15 um) (Electron Microscopy Sciences) on the glass during the coating process forming 100 um²gold pads on the glass surface. A slot grid (200×600 um) or a single hole grid (600 nm) can alternatively be used to pattern the surface. In preliminary studies, it has been observed that antibodies bind tenaciously to bare (clean) gold surfaces and retain some level of biological activity. The virus particles can also bind to gold and create a background problem.

[0038] Passive adsorption was utilized to attach protein G to the gold surface to keep the non-specific binding of the virus particles to a minimum. Protein G is utilized as a layer over the surface because protein G presents four binding sites and orients the antibodies. Protein G is a naturally occurring protein that binds tightly to the Fe region of antibodies, in particular, IgG. In addition, when an antibody is deposited on the protein G, each antibody will orient in a specific manner relative to the surface. Control of the manner in which the antibodies orient relative to the surface insures that more of the active antibody binding site is exposed and active. In one alternative embodiment for passive adsorption, another protein can be used, for example, protein A (similar to protein G) or a hybrid protein A/G, (a recombinant mixture of protein A and protein G that combines the binding characteristics of both). In other embodiments, the chip may utilize the deposited gold surface to bind the antibody to the surface in a non-specific way. In still further embodiments, the gold surface can be covered with an alkanethiolate material so that the deposited antibody coupled to the surface in a very specific manner, e.g., chemically (see Example II below).

[0039] To deposit the protein G layer, the glass substrates with the freshly prepared gold pads are immersed in a protein G (Sigma) solution at 1 mg/ml in 1×PBS (10 mM phosphate buffer, 137 mM NaCl and 1.37 mM KCl) at room temperature for 30 minutes. Protein G is passively absorbed onto the prepared gold surface forming a uniform protein surface over the gold coated glass substrates. The substrate was then removed from the protein solution, washed with filtered distilled water, blown dry with argon, and stored at 4° C. until antibody deposition.

[0040] Antibodies can be deposited on the surface using a microjet device similar to the inkjet used in a inkjet printer. The microjet apparatus and method uses an aerosol microdroplet to create domains of the antibody on the surface. In the present embodiment, a single microjet, with a 30 um nozzle, and a MicroJet III controller (MicroFab Technologies, Inc., Texas) was used. The microjet was mounted on custom-built computer controlled stage with translation along the X, Y and Z axes. Deposition domains of anti-viral antibodies on the order of few tens of microns were created in the protein G surface.

[0041] The microjet method offers the advantage of extensive field testing and previous utilization in commercial applications involving genome arrays. The microjet uses a piezoelectric pump for precise delivery of fluids in the nanoliter to picoliter range. The microjet can consistently make arrays of antibodies with spot sizes in the 30-80 um diameter range separated by 20 um. Using spot sizes of 50 um and inter spot distance of 20 um, production of a 2×2 array in a 120×120 um area can be achieved. The AFM scan range is approximately 120 um and therefore can interrogate all four spots in a single AFM scan field.

[0042] Subsequent to antibody deposition, the substrates were re-hydrated by placing them in a high humidity environment for 30 minutes, such an environment may be greater than 50% more preferably about 90%. Exposing the chip to high humidity and re-hydrating the chip helps the antibody to bind to the protein G surface.

[0043] Typical viral diameters may range from about 20-200 nm. It is not crucial for every antibody to retain biological activity, therefore, because the viral particles are significantly larger than a single antibody and will cover a field of several antibodies. A virus with a radius of 25 nm (roughly the size of the CPV) would cover an area of about 500 nm²when touching a surface with sufficient molecular flexibility to permit antibodies to gain access to 25% of the viral surface. The antigen binding site of an antibody covers a spatial envelope of approximately 2 nm×5 nm, or 10 nm². Therefore, if only 20% of the antibodies on the surface were correctly oriented and biologically active, the viral particle would contact about 10 potential binding sites. Based on these considerations the present embodiment uses chemisorbed antibodies for the construction of the solid state viral detection and identification assay.

[0044] The chip is then exposed to the target sample and tested for any molecular interaction events between the deposited material and the target material.

[0045] As illustrated in FIG. 1, the present invention utilizes an atomic force microscope as the detection apparatus. In an AFM, the interactions between a sharp, micron-scale probe and a sample are monitored and regulated as the probe scans over the sample. Extremely fine control of the motion of the AFM probe is achieved using piezoelectric crystals. Thus, the AFM is capable of ˜2 nm lateral resolution and <1 nm vertical resolution. This level of resolution gives the AFM the ability to detect changes in topography in the Angstrom range. The ability of AFM to detect height changes on the order of 1 nm has been utilized for the detection of antibody-antigen interaction; AFM has also been used to image nucleic acids, proteins, viruses, bacteria, live cells and other biological materials. The AFM can be operated in solution and is capable of identifying molecular binding events in near-real time. For a typical AFM immunoassay, the change in height is on the order of 1-3 nanometers (nm), providing a change in signal of 100% (from 3 to 6 nanometers, for example). For viruses, this change is much greater, on the order of 30 to 300 nm, providing a signal to noise ratio of 10 to 100 fold.

[0046] A Dimension 3000 series AFM (Digital Instruments/Veeco, Santa Barbara, Calif.) equipped with a 120-um tube scanner was utilized for the large-scale topography measurements of the chip. All images were captured in Tapping mode using silicon ultralevers (Park Instruments) under ambient conditions. Images were flattened and low pass filtered for analysis.

[0047] Although the present embodiment utilizes the AFM as a label-free detection device, alternative methods including, but not limited to, surface plasmon resonance, mass spectrometry, electronic signature, optical methods, or other techniques, can be incorporated into the present invention without changing the nature and scope thereof.

Example I

[0048] With reference to FIGS. 2a-b, 4a-c, 5a, 6a-c, and 7a-c, CPV is detected by constructing a chip with anti-canine parvovirus monoclonal antibody deposited thereon, exposing the chip to a target sample, and then reading the chip using the AFM to determine whether CPV is bound to the chip surface.

[0049] The viral particles were prepared at a stock concentration of 0.3 mg/ml. Purified monoclonal antibody which recognizes the CPV capsid, A3B10 (0.9 mg/ml) was utilized. In another test run, purified anti-canine parvovirus monoclonal antibody (2 mg/ml) was obtained from a separate source (Custom Monoclonal International, California) with no observable change in results.

[0050] A chip with a protein G coated surface was used for the deposition of antibodies against CPV at specific regions. The domains were formed using the above described microjet method. The antibodies of the present embodiment were diluted to 0.1 mg/ml in 1×PBS before being deposited onto the surface using the microjet. The microjet was back-loaded with a syringe and the anti-viral antibodies were deposited on the surface with spot sizes in the range of 40 to 80 um. After all the antibodies spots were deposited, the chips were incubated in a humid environment for 30 minutes at room temperature to allow the antibodies to bind to the protein G surface. The chips were then washed with distilled water, blown dry with Argon and stored at 4° C. until used.

[0051] After the desired surface was formed on the chip, the chip was washed with distilled water and imaged to insure the surface was clean and smooth with no particulate matter thereon. Such an image is seen in FIGS. 7a and 6a. The present embodiment utilized incubation of the antibody with the chip to expose the deposition material to the target material. The chips were incubated with the target sample, in this case 200 μl of virus detection buffer (PBS containing 0.25 mM NaCl, and 0.2% tween-80) on a rocker platform at room temperature for 15 min. During the incubation with CPV, the virus binds not only to the specific domain on the chip with CPV antibodies but also binds non-specifically to other regions on the chip. See FIG. 6b. Following incubation, the chips were washed three times in wash buffer (PBS containing 0.4 M NaCl and 0.2% T-80), each for 10 min. and once in water. This removes the non-specifically bound virus (FIG. 6c). Each chip was rinsed in water and blown dry in a stream of argon and then imaged by AFM. The chips may be incubated in 2 μl at high CPV concentrations (>100 ng/ml). At lower viral concentrations, the chips can be incubated in 200 μl of viruses in the target sample detection buffer for varying lengths of times on a rocker at room temperature.

[0052] Results

[0053] The above steps were used to test samples containing CPV at various concentrations. Afterwards, each chip was imaged and a particle count analysis was performed. Five sets of data were collected and plotted on a graph with the time on the X-axis and number of virus particles bound on the Y-axis. As seen in FIG. 8, as the concentration decreases the number of virus particles bound at any given time also decreases. Also, at any concentration the binding profile seems to follow a standard asymptotic curve as would be seen for a single step binding profile.

[0054] The regions where the CPV antibodies were deposited had virus particles bound to it (>500 particles/5 um region). Areas where no antibodies were bound had very few virus particles bound to it (<10 particles/5 um region). The bindings where no CPV antibody was deposited can be attributed to non-specific interactions between the virus with the protein G surface. See FIGS. 7a-c.

[0055] By performing a dilution series experiment with CPV, it was determined that virus particles can be detected at a concentration of 300 pg/ml. The CPV genome is about 5 kilobases of single stranded DNA. Assuming the molecular weight of the total DNA is equal to that of the proteins, the molecular weight of the empty capsids would be about 2000 kDa., then 1 μg of the empty capsids would have about 3×10¹¹particles (stock concentration of 10¹⁴particles/ml). These numbers indicate that viruses at a titer of 10⁷particles/ml will provide a signal that is sufficient to report the presence of a particular virus.

[0056] More quantitative data analysis can be performed to relate the degree of observed binding to the sample concentration. For example, since the number of particles observed is a function of time, which is derivative of the sample concentration, it is possible to carry out a time course and determine an absolute sample concentration. The number of viruses bound at several time points, for example, 1, 5, 20 and 60 minutes, is measured. This can be compared to a standard curve for virus at known concentrations. Since the binding is driven by diffusion and therefore the number of binding events per unit time is a function of concentration, one can calculate the concentration of the unknown virus by fitting the binding vs. time curve to the standard curve obtained using the known concentrations of virus.

[0057] This data can be coupled with morphological analyses, local adhesion, elasticity, viscosity, or other analyses of which the AFM is capable, to create a multidimensional database of information which greatly enhances the identification and characterization of materials bound to the sensor surface.

[0058] FIGS. 7a-c represent AFM scans of a chip surface. The upper image shows a two dimensional rendering in which scale indicates topographical features. Lighter intensity features are taller than darker features (total Z range 300 nm) and the field size is 2 μ×2 μ. The lower image is a 3D projection of the same data. FIG. 7b shows the surface after reaction with CPV. The lighter features correspond to the presence of bound CPV particles.

[0059] An example image of the virus binding to the microarray using AFM is illustrated in FIGS. 2a-b. Thus, when no sample is present, the deflection of the probe is due to the presence of the capture probe (Control). When sample is bound to the capture probe, the increased height of the deflection is due to the bound, large molecular weight particle sitting on top of the capture probe and is clearly detected (Positive). This analysis allows for quantification of particles bound to the chip by integrating the number of capture probes per spot bound to target particles.

[0060] As illustrated in FIGS. 6a-c, each antibody specific for a unique virus can be spotted on a distinct domain. When the entire chip surface is exposed to the virus, viral particles will bind strongly to the domain with its specific antibodies but will also non-specifically bind weakly to other domains. See FIG. 6b. After washing the chip surface, most of the weak, non-specific binding of the antigen is removed and remaining surface binding of the antigen is specific to the domain with its antibody. See FIG. 6c.

[0061] In the present invention, the results of binding can be checked by utilizing a control. A control is effectuated by exposing the virus to a chip, which does not have a binding affinity to the target material. In the present embodiment, the chip for detecting TGEV was exposed to CPV. FIG. 7a shows the chip surface as detected by AFM with no analyte added (control). FIG. 7c shows a chip against Transmissible Gastroenteritis Virus (TGEV), reacted with CPV, which should not bind to the anti-TGEV antibody on the chip (non-specific binding). In this case, very little non-specific binding occurs, as reflected by the absence of raised features (viral particles). Such a rendering was also performed with antibodies against CDV (Canine Distemper Virus) with similar results. (Purified Monoclonal Anti distemper virus antibody (0.1 mg/ml) was obtained (Biodesign International, Maine)).

Example Ii

[0062] Anti-vaccinia and anti-adenovirus (control) antibodies were obtained from Biodesign. Vaccinia virus strain WR (American Type Culture Collection (ATCC) 1354) was grown in HeLa S3 (ATCC CCL-2.2) cells maintained on RPMI 1640 supplemented with 7% v/v fetal bovine serum and penicillin, streptomycin and fungizone. Near confluent S3 cells in Blake bottles were infected at a multiplicity of infection (MOI) of 0.2. Cells were collected when detachment became apparent in about 3 days. Virus was purified from frozen and thawed cells by successive cycles of sedimentation velocity and equilibrium density centrifugation. Stocks of purified virus were titered by end-point dilution assays and stored at −80C. The virus had a stock concentration of 10⁷pfu/ml. The purified rabbit anti-vaccinia (B65101R lot 8304600) and goat anti adenovirus hexon (B65101G, lot 4A01901) antibodies were divided into aliquots and stored at −20 C. until use.

[0063] To construct the vaccinia chips, the process of active immobilization to adhere anti-vaccinia antibodies to the chip surface was utilized instead of the passive adsorption to a protein layer as described in Example I above. In contrast, few adenovirus particles bind to the vaccinia chip demonstrating the specificity of vaccinia chip. Further characterization of the vaccinia chip showed that the binding of vaccinia to the chip was linear with time for the first 12 hours with a maximum of 200 particles attached in a 900 μ²area viewed by AFM.

[0064] The anti-vaccinia binding agent can be tethered to the surface by first placing an alkanethiolate monolayer over the gold. The anti-vaccinia virus would then be reacted with a —COOH group on the exposed portion of the alkanethiolate. In other embodiments, the binding agent can be tethered with a succinimide group or a NH₂group.

[0065] The virus retains its typical brick-like morphology. The virus may retain some or all of its infectivity as the placement of the washed and dried chip onto a HeLa S3 monolayer resulted in infection from which infectious vaccinia virus was obtained.

[0066] The anti-adenovirus antibody in the heterologous experiment did exhibit a few bound virions. The ratio of homologous to heterologous signal in several experiments using these antibodies is about one log. Typically 3-8 vaccinia particles were detected in a 900 μ²field using anti-adenovirus.

[0067] For actively immobilized antibody attachment to chip surfaces, freshly prepared gold surfaces, which were patterned through a slot grid or a single-hole grid, were immersed overnight at room temperature in a 0.5 mm ethanolic solution of 16-mercaptohexadecanoic acid. The surfaces were rinsed in ethanol and activated by incubating in 1-Ethyl-3-(3-Dimethylaminopropyl)carbodiimide (EDC) (10 mg/ml in 100 mM (2-(N-Morpholino)ethanesulfonic acid) (MES) buffer pH 4.8) at room temperature for 2 hours. Each chip was rinsed in PBS and blown dry in a stream of dry argon. The central gold pattern (formed by the slot grid) were covered with 1 μl of the antibodies (0.1 mg/ml in PBS) and incubated at room temperature for 2 hours. The chips were then rinsed in PBS and the un-reacted chip surface was blocked by incubating in 10 mM methylamine in PBS for 30 minutes. The chips were washed with water, blown dry and stored at 4° C.

[0068] From an assay that contained 10⁵infectious doses per ml and an estimated particle number of 10⁶based upon TEM the assay was linear with time for the first 12 hours with a maximum of 200 particles attached in a 900 μ²viewed by AFM.

[0069] Binding was a function of concentration. Increasing the concentration by 30 fold resulted in a 30-fold increment in virus numbers observed.

[0070] Alternative Embodiments

[0071] In one alternative embodiment, larger spots can be used in conjunction with a mechanism for rapid translation of the sample under the scanning probe. In this embodiment, spot sizes of 60-100 μ diameter can be positioned a few tens of microns apart in the array. The AFM would then scan the spots in a known order, relying on accurate translation of the spots to the interrogation field. This operation may be readily accomplished using a conventional high resolution translation stage. Throughput would not be compromised because faster scan rates (e.g., 3 Hz vs. 1 Hz) and lower resolution (e.g. 256 vs. 512 lines per scan) data could be employed to offset the additional time required to physically translate the stage without introducing intolerable degradation of data.

[0072] As may be appreciated, the invention can be applied to detection and characterization of a broad range of biological materials, such as, but not limited to, other viruses, bacteria, bacterial spores, prions, pathogenic microbes such as fungus, parasites, mold, and pollen spores.

[0073] The information and examples described herein are for illustrative purposes and are not meant to exclude any derivations or alternative methods that are within the conceptual context of the invention. It is contemplated that various deviations can be made to this embodiment without deviating from the scope of the present invention. Accordingly, it is intended that the scope of the present invention be dictated by the appended claims rather than by the foregoing description of this embodiment.

Claims

1. A method of detecting a target pathogen, comprising the steps of:

providing a substrate with a surface;

depositing a patterned gold layer on the surface;

depositing a deposition material on the surface, the deposition material capable of interacting with the target pathogen; and

exposing the deposition material to a target sample which can contain the target pathogen and detecting resultant molecular interaction events between the deposition material and the target pathogen by imaging the surface with an atomic force microscope.

2. The method of claim 1 wherein the pathogen is a virus and the deposition material is an antibody.

3. The method of claim 1 wherein the surface is chosen from the group consisting of glass and silicon.

4. The method of claim 1 wherein the patterned gold layer is sputtered on the surface.

5. The method of claim 1 wherein the surface further comprises a layer of chromium.

6. The method of claim 2 wherein the antibody is attached to the surface by spontaneous adsorption.

7. The method in claim 2 wherein the antibody is chemically tethered to the surface.

8. The method of claim 2 further comprising depositing an orienting protein layer on the surface to orient the antibody.

9. The method in claim 8 wherein the orienting protein is chosen from a group consisting of Protein A, Protein G and Protein A/G.

10. The method of claim 8 wherein the orienting protein is passively adsorbed on the gold surface.

11. The method in claim 8 wherein orienting protein is chemically tethered to the surface.

12. The method of claim 8 further comprising covalently attaching a C11-C18 alkane linker to the gold layer.

13. The method in claim 12 wherein the alkane linker includes a functional portion selected from a group consisting of a COOH, a NH₂, and a succinimide.

14. The method of claim 12 wherein the alkane linker interacts with a primary amine of the protein.

15. The method of claim 2 wherein the antibody is deposited using an inkjet.

16. The method of claim 15 wherein the antibody is deposited in a deposition domain on the surface.

17. The method of claim 8 wherein depositing the antibody to the orienting protein further comprises incubating the surface with the antibody thereon in a humid environment to allow the antibodies to passively bind to the orienting protein.

18. The method in claim 17 wherein the excess antibodies are washed from the surface following the binding event.

19. The method of claim 2 wherein the virus is canine parvovirus.

20. The method of claim 19 wherein the antibody is anti parvovirus.

21. The method of claim 2 further comprises exposing the virus to a control antibody.

22. The method of claim 21 wherein the control antibody is anti-transmissible gastroenteritis virus.

23. The method of claim 21 wherein the control is anti-canine distemper virus.

24. The method of claim 2 wherein the virus is a vaccinia virus.

25. The method of claim 24 wherein the antibody is a monoclonal antibody directed against a vaccinia virus.

26. An apparatus for the detection of a vaccinia virus, comprising

a gold layer deposited on a substrate;

an C(x) alkane linker covalently attached to the gold layer;

a protein A/G tethered to the surface through the alkane linker; and

anti-vaccinia antibody deposited on the surface in a domain such that a portion of the deposited antibody retains activity.

27. The apparatus of claim 26 wherein the substrate, the gold layer, alkane linker layer, protein A/G and the antibody deposited thereon form a chip.

28. The apparatus of claim 26 wherein x is a carbon backbone of 11 to 18 carbons in length terminating with a succinimide group.

29. The apparatus of claim 26 wherein the apparatus further comprises a control antibody deposited on the surface in a domain.

30. The apparatus of claim 29 wherein the control is anti-adenovirus antibody.

31. The apparatus of claim 26 wherein the antibody is microjet deposited.

32. The apparatus of claim 26 wherein the substrate is selected from the group consisting of glass and silicon.

33. The apparatus of claim 26 wherein the gold layer is deposited on the surface in a grid pattern.

34. The apparatus of claim 33 wherein the grid pattern is a 400 mesh grid with a hole size of 100 um and a bar size of 15 um.

35. The apparatus of claim 33 wherein the grid pattern is a slot grid of 200 um by 600 um.

36. The apparatus of claim 33 wherein the grid pattern is a hole grid pattern of 600 um.

37. A method of detecting a target pathogen, comprising the steps of:

providing a substrate with a surface;

depositing a deposition material on the surface, the deposition material capable of interacting with the target pathogen;

exposing the deposition material to a target sample which can contain the target pathogen and detecting resultant molecular interaction events between the deposition material and a target pathogen.

38. The method of claim 37 further comprising depositing a second deposition material on the surface capable of interacting with a second target pathogen before exposing the deposition material to a target sample which can container one or more of the target pathogens.

39. The method of claim 37 wherein the deposition material is a virus and the target pathogen is a virus.

40. The method of claim 37 wherein the deposition material is an aptamer.

Patent Citations (118)

Patent	Date	Inventor	Cited By
US4728591(A)	1988-03-01	Clark et al.	Applicant
US5106729(A)	1992-04-01	Lindsay et al.	Applicant
US5138174(A)	1992-08-01	Tang	Applicant
US5143854(A)	1992-09-01	Pirrung et al.	Applicant
US5314829(A)	1994-05-01	Coles	Applicant
US5346683(A)	1994-09-01	Green et al.	Applicant
US5363697(A)	1994-11-01	Nakagawa	Applicant
US5372930(A)	1994-12-01	Colton et al.	Applicant
US5384261(A)	1995-01-01	Winkler et al.	Applicant
US5440122(A)	1995-08-01	Yasutake	Applicant
US5443791(A)	1995-08-01	Cathcart et al.	Applicant
US5445934(A)	1995-08-01	Fodor et al.	Applicant
US5445971(A)	1995-08-01	Rohr	Applicant
US5453970(A)	1995-09-01	Rust et al.	Applicant
US5467642(A)	1995-11-01	Hosaka et al.	Applicant
US5472881(A)	1995-12-01	Beebe et al.	Applicant
US5482601(A)	1996-01-01	Ohshima et al.	Applicant
US5514540(A)	1996-05-01	Teoule et al.	Applicant
US5514550(A)	1996-05-01	Findlay et al.	Applicant
US5519212(A)	1996-05-01	Elings et al.	Applicant
US5532128(A)	1996-07-01	Eggers et al.	Applicant
US5571639(A)	1996-11-01	Hubbell et al.	Applicant
US5601982(A)	1997-02-01	Sargent et al.	Applicant
US5604097(A)	1997-02-01	Brenner	Applicant
US5620854(A)	1997-04-01	Holzrichter et al.	Applicant
US5666190(A)	1997-09-01	Quate et al.	Applicant
US5670322(A)	1997-09-01	Eggers et al.	Applicant
US5688486(A)	1997-11-01	Watson et al.	Applicant
US5720928(A)	1998-02-01	Schwartz	Applicant
US5744305(A)	1998-04-01	Fodor et al.	Applicant
US5753088(A)	1998-05-01	Olk	Applicant
US5760300(A)	1998-06-01	Kajimura	Applicant
US5763768(A)	1998-06-01	Henderson et al.	Applicant
US5789167(A)	1998-08-01	Konrad	Applicant
US5800992(A)	1998-09-01	Fodor et al.	Applicant
US5837832(A)	1998-11-01	Chee et al.	Applicant
US5840862(A)	1998-11-01	Bensimon et al.	Applicant
US5846724(A)	1998-12-01	Bensimon et al.	Applicant
US5851769(A)	1998-12-01	Gray et al.	Applicant
US5866328(A)	1999-02-01	Bensimon et al.	Applicant
US5866434(A)	1999-02-01	Massey et al.	Applicant
US5874219(A)	1999-02-01	Rava et al.	Applicant
US5874668(A)	1999-02-01	Xu et al.	Applicant
US5958701(A)	1999-09-01	Green et al.	Applicant
US5965133(A)	1999-10-01	Cantor et al.	Applicant
US5981733(A)	1999-11-01	Gamble et al.	Applicant
US5985356(A)	1999-11-01	Schultz et al.	Applicant
US5992226(A)	1999-11-01	Green et al.	Applicant
US5993627(A)	1999-11-01	Anderson et al.	Applicant
US6004617(A)	1999-12-01	Schultz et al.	Applicant
US6024925(A)	2000-02-01	Little et al.	Applicant
US6033911(A)	2000-03-01	Schultz et al.	Applicant
US6045671(A)	2000-04-01	Wu et al.	Applicant
US6080586(A)	2000-06-01	Baldeschwieler et al.	Applicant
US6083763(A)	2000-07-01	Balch	Applicant
US6087274(A)	2000-07-01	Tonucci et al.	Applicant
US6110426(A)	2000-08-01	Shalon et al.	Applicant
US6123819(A)	2000-09-01	Peeters	Applicant
US6143574(A)	2000-11-01	Karlsson et al.	Applicant
US6146899(A)	2000-11-01	Porter et al.	Applicant
US6159742(A)	2000-12-01	Lieber et al.	Applicant
US6171797(B1)	2001-01-01	Perbost	Applicant
US6180114(B1)	2001-01-01	Yager	Applicant
US6200737(B1)	2001-03-01	Walt et al.	Applicant
US6203814(B1)	2001-03-01	Fisher et al.	Applicant
US6214552(B1)	2001-04-01	Heroux et al.	Applicant
US6218122(B1)	2001-04-01	Friend et al.	Applicant
US6231744(B1)	2001-05-01	Ying et al.	Applicant
US6232706(B1)	2001-05-01	Dai et al.	Applicant
US6239273(B1)	2001-05-01	Pease et al.	Applicant
US6255469(B1)	2001-07-01	Seeman et al.	Applicant
US6270946(B1)	2001-08-01	Miller	Applicant
US6278231(B1)	2001-08-01	Iwasaki et al.	Applicant
US6284497(B1)	2001-09-01	Sabanayagam et al.	Applicant
US6287850(B1)	2001-09-01	Besemer et al.	Applicant
US6289717(B1)	2001-09-01	Thundat et al.	Applicant
US6309831(B1)	2001-10-01	Goldberg et al.	Applicant
US6329209(B1)	2001-12-01	Wagner et al.	Applicant
US6331396(B1)	2001-12-01	Silverman et al.	Applicant
US6350609(B1)	2002-02-01	Morozov et al.	Applicant
US6395554(B1)	2002-05-01	Regan et al.	Applicant
US6406921(B1)	2002-06-01	Wagner et al.	Applicant
US6416952(B1)	2002-07-01	Pirrung et al.	Applicant
US6420105(B1)	2002-07-01	Landfield et al.	Applicant
US6436647(B1)	2002-08-01	Quate et al.	Applicant
US6518168(B1)	2003-02-01	Clem et al.	Applicant
US6573369(B2)	2003-06-01	Henderson et al.	Applicant
US20020042081(A1)	2002-04-01	Henderson et al.	Applicant
US20020063212(A1)	2002-05-01	Mirkin et al.	Applicant
US20020076927(A1)	2002-06-01	Henderson et al.	Applicant
US20020114987(A1)	2002-08-01	Oscarsson et al.	Applicant
US20020122873(A1)	2002-09-01	Mirkin et al.	Applicant
US20020123135(A1)	2002-09-01	Henderson et al.	Applicant
US20020146714(A1)	2002-10-01	Lieber et al.	Applicant
US20020172943(A1)	2002-11-01	Henderson et al.	Applicant
US20020179434(A1)	2002-12-01	Dai et al.	Applicant
US20030013111(A1)	2003-01-01	Henderson et al.	Applicant
JP6124680	1994-05-01		Applicant
WO9215709	1992-09-01		Applicant
WO9631775	1996-10-01		Applicant
WO9706420	1997-02-01		Applicant
WO9718326	1997-05-01		Applicant
WO9805920	1998-02-01		Applicant
WO9818959	1998-05-01		Applicant
WO9931267	1999-06-01		Applicant
WO4382	2000-01-01		Applicant
WO4389	2000-01-01		Applicant
WO4390	2000-01-01		Applicant
WO36136	2000-06-01		Applicant
WO41213	2000-07-01		Applicant
WO46406	2000-08-01		Applicant
WO160316	2001-08-01		Applicant
WO1918555	2001-12-01		Applicant
WO3001633	2003-01-01		Applicant
WO3036767	2003-05-01		Applicant
WO3038033	2003-05-01		Applicant
WO3048314	2003-06-01		Applicant
WO3052514	2003-06-01		Applicant

Non-Patent Literature (250)

U.S. Appl. No. 09/974,757, filed Apr. 11, 2002, Henderson et al.Applicant
U.S. Appl. No. 09/929,865, filed Jun. 20, 2002, Henderson et al.Applicant
U.S. Appl. No. 10/179,102, filed Jan. 16, 2003, Henderson et al.Applicant
U.S. Appl. No. 10/160,372, filed Nov. 21, 2002, Henderson et al.Applicant
U.S. Appl. No. 10/128,727, filed Sep. 5, 2002, Henderson et al.Applicant
U.S. Appl. No. 09/574,519, filed Jun. 2003, Henderson et al.Applicant
“Microbeam Mass Spectrometry” Chemical Science and Technology Laboratory, Surface and Microanalysis Science Division http://www.cstl.nist.gov/div837/Division/expertise/ions/masspecl.htm Jul. 18, 2002.Applicant
Abstracts of Papers Part I, 214th “Abstract 027” ACS National Meeting American Chemical Society, Sep. 1997, 2 pgs.Applicant
Allison, D., et al., “Direct atomic force microscopy imaging of EcoRI endonuclease site specifically bound to plasmid DNA molecules” PNAS USA, 1996, 93:8826-8829.Applicant
Allison, D., et al., “Mapping Individual Cosmid DNAs by Direct AFM Imaging” Genomics, 1997, 41:379-384.Applicant
Alves, et al., Atomic scale imaging of alkanethiolate monolayers at gold surfaces with atomic force microscopy: J. Am. Chem. Soc., Feb. 1992, 114(4):1222-1227.Applicant
Amro, et al., “Patterning surfaces using tip-directed displacement and self-assembly” Langmuir, 2000, 16:3006-3009.Applicant
Anwander, et al., “Surface characterization and functionalization of MCM-41 silicas via silazane silylation” J. Phys. Chem. B., 2000, 104:3532-3544.Applicant
Arntz, et al., “Label-free protein assay based on a nanomechanical cantilever array” Nanotechnology, 14 (2003) 86-90.Applicant
Ausubel, F.M., et al. “Current Protocols in Molecular Biology” 1993 ed. vol. 1&2, 1993, Green Publishing Associates and Wiley-Interscience. Table of contents only.Applicant
Collins, et al., “Engineering Carbon Nanotubes and Nanotube Circuits Using Electrical Breakdown,” Apr. 2001, 292(5517):706-799.Applicant
Bailey, C.P., et al., Cationic oligonucleotides can mediate specific inhibition of gene expression in Xenopus oocytes Nuc. Acids Res., 1998, 26(21):4860-4867.Applicant
Bain, et al., “Modeling organic surfaces with self-assembled monolayers” Agnew. Chem. Int. Ed. Engl., 1989, 28(4):506-512.Applicant
Baselt, D.R., et al., “A biosensor based on magnetoresistance technology” Biosens. Bioelectorn, 1998, 13(7-8):731-739.Applicant
Bedouelle, H., “Reagentless fluorescent Immunosensors” Antibody Engineerings, IBC's 13th International Conference, Dec. 2, 2002.Applicant
Belaubre, P. et al., “Fabrication of biological microarrays using microcantilevers” Applied Physics Letters, May 5, 2003, 82(18):3122-3124.Applicant
Bensimon, A., et al., “Alignment and sensitive detection of DNA by a moving interface” Science, Sep. 30, 1994; 265(5181):2096-2098 [PMID 7522347] Abstract.Applicant
Berggren, et al., “Microlithography by using neutral metastable atoms and self-assembled monolayers” Science, Sep. 1995, 269(5228):1255-1257.Applicant
Bernard, et al. “Printing patterns of proteins” Langmuir The ACS Journal of Surfaces and Colliod, Apr. 1998, 14(9):2225-2229.Applicant
Binggeli, et al., “Influence of capillary condensation of water on nanotribology studied by force microscopy” Appl. Phys. Lett., Jul. 1994, 65(4):415-417.Applicant
Binning, et al., “Surface studies by scanning tunneling microscopy” Phys. Rev. Lett., 1982, 49(1):57-61.Applicant
Binning, G., et al., Atomic force microscope Phys. Rev. Lett., 1986, 56(9):930-933.Applicant
Bishop, et al., “Self-assembled monolayers: recent developments and applications” Colloid & Interface Science, Feb. 1996, 1:127-136.Applicant
Bottomley, L., “Scanning probe microscopy” Anal. Chem., Jun. 1998, 70(12):425R-475R.Applicant
Brandow, S., et al., “Metal pattern fabrication using the local electric field of conducting atomic force microscope probe” J. Vac. Sci. Technol., May/Jun. 1997, 15(3):1455-1459.Applicant
Brenner, S., et al., “Gene expression analysis by massively parallel signature sequencing (MPSS) on microbead arrays” Nat. Biotechnol 2000, Jun. 18(6):630-634, 2000.Applicant
Brody, E., and Gold, L., “Aptamers as therapeutic and diagnostic agents” Molecular Biotechnology, 2000, 74:5-13.Applicant
Bruckbauer, et al., “Writing with DNA and Protein Using a Nanopipet for Controlled Delivery” JACS, 2002, A-B.Applicant
Bulyk, et al., “Quantifying DNA-protein interactions by double-stranded DNA arrays” Nature Biotechnology, Jun. 1999, 17:573-577.Applicant
Bustamante C., et al., “Circular DNA Molecules Imaged in Air by Scanning Force Microscopy” Biochemistry, 1992, 31:22-26.Applicant
Bustamante, C., et al., “Biochemical and structural applications of scanning force microscopy” Curr. Opin. Struct. Biol., 1994 4(5):750-760.Applicant
Carr, et al., “High-selectivity pattern transfer process for self-assembled monolayer electron beam resists” J. Vac. Sci. Technol., May/Jun. 1997, 15(3):1446-1450.Applicant
Cheng, et al., “Preparation and hybridization analysis of DNA/RNA from E. coli on microfabricated bioelectronic chips” Nature Biotechnology, 1998, 16:541-546.Applicant
Chrisey et al, “Fabrication of patterned DNA surfaces” Nucleic Acids Research, (Oct. 1996)24(15):3040-3047.Applicant
Clark, M.W. et al., “Nanotechnology tools for functional proteomics analysis” American Biotechnology Laboratory, Mar. 2001, 16-18.Applicant
Colas, et al., “Genetic selection of peptide aptamers that recognize in inhibit cyclin-dependent kinase 2”, Nature, Apr. 1996 380(11):548-550.Applicant
Colvin, et al. “Semiconductor nanocrystals covalently bound to metal surfaces with self-assembled monolayers” J. Am. Chem. Soc., 1992, 114:5221-5230.Applicant
Cui, Y, et al., “Nanowire nanosensors for highly sensitive and selective detection of biological and chemical species” Science, 2001, 293, 1289-1292.Applicant
Dai, et al., “Nanotube Molecular Wires as Chemical Sensors” Science, Jan. 28, 2000, 287:622-625.Applicant
Dai, H, et al., “Controlled chemical routes to nanotube architectures” Physics and Devices, J. Phys. Chem B, 1999, 103:11246-11255.Applicant
Dai, H, et al., “Probing electrical transport in nanomaterials: conductivity of individual carbon nanotubes” Science, 1996, 272(5261):523-526.Applicant
Dammer, et al., “Binding strength between cell adhesion proteoglycans measured by atomic force microscopy” Science, 1995, 267:1173-1175.Applicant
Dammer, et al., “Specific antigen/antibody interactions measured by force microscopy” Biophys. J., 1996, 70:2437-2441.Applicant
Delamarch, E., et al., “Patterned delivery of immunoglobulins to surfaces using microfluidic networks” Science, 1997, 276:779-781.Applicant
Ding, Y., Oka, T., et al., “Near-field stimulated TOF nanometric surface mass spectroscopy: characterization of Nano-localized surfaces” Joint International Meeting—200th Meeting of the Electrochemical Society, Inc., 52nd Annual Meeting of the International Society of Electrochemistry, San Francisco, California (2001).Applicant
Ding, Y., Ruggero, M. et al., “Development of UHV-STM/TOF hybrid mass analyzer system for nano-characterization of metal silicide surfaces” 198th Meeting of the Electrochemical Society, Phoenix, Arizona (2000).Applicant
DeRisi, et al., “Exploring the Metabolic and Genetic Control of Gene Expression on a Genomic Scale” Science, Oct. 1997, 278:680-686.Applicant
Dong, Y. and Shannon, C., “Heterogeneous Immunosensing Using Antigen and Antibody Monolayers on Gold Surfaces with Electrochemical and Scanning Probe Detection” Anal. Chem., 2000, 72:2371-2376.Applicant
Dontha, N., et al., “Development of sub-micron patterned carbon electrodes for immunoassays” J. Pharm. Biomed. Analysis, (Feb. 1999) 19:83-91.Applicant
Dontha, N., et al., “Generation of Biotin/Avidin/Enzyme Nanostructures with Maskless Photoligography” Anal. Chem., 1997, 69: 619-2625.Applicant
Dubois, L. et al., “Synthesis, Structure, and Properties of Model Organic Surfaces” Annu. Rev. Phys. Chem., 1992, 43:437-463.Applicant
Durbin, S., Feher, G., “Protein crystallization” Annual Review of Phys Chemistry, 1996, 47:171-204.Applicant
Falvo, M.R., et al., “Bending and buckling of carbon nanotubes under large strain” Nature, 1997, 389:582-584.Applicant
Fan, S., et al., “Self-oriented regular arrays of carbon nanotubes and their functional devices” Science, 1999, 283, 512.Applicant
Fang, et al., “Membrane Protein Microarrays” JACS, 2002, 124(11):2394-2395.Applicant
Farajian, A.A., “Nanolinear Coherent Transport Through Doped Nantube Junctions” Physical Review, Jun. 21, 1999, 82(25):5084-5087.Applicant
Feigon, J. “DNA triplexes, quadruplexe, and aptamers” Clin. Chem., 1994, 40(4):647-647.Applicant
Florin, E., et al., “Adhesion forces between individual ligan-receptor pairs” Science, 1994, 264:415-417.Applicant
Fodor, S., et al., “Light-directed spatially addressable parallel chemical synthesis” Science 1991, 251: 767-773.Applicant
Fodor, S., et al., “Multiplexed biochemical assays with biological chips” Nature, 1993, 364:555-557.Applicant
Frisbie, C.D. et al., “Functional group imaging by chemical force microscopy” Science, 1994, 265:2071-2074.Applicant
Fritz, J., et al., “Translating biomolecular recognition into nanomechanics” Science, 2000, 316-318.Applicant
Fritzsche, W., et al., “Application of Atomic Force Microscopy to Visualization of DNA, Chromatin and Chromosomes” Critical Reviews™ in Eukaryotic Gene Expression, 1997, 7(3):231-240.Applicant
Fritzsche, W., et al., “Chicken Erythrocyte Nucleosomes Have a Defined Orientation along the Linker DNA-A Scanning Force Microscopy Study” Scanning, 1997, 19:42-47.Applicant
Fritzsche, W., et al., “Mapping elasticity of rehydration metaphase chromosomes by scanning force microscopy” Ultramicroscopy, 1997, 69:191-200.Applicant
Fritzsche, W., et al., “Ribosomes substructure investigated by scanning force microscopy and image processing” Journal of Microscopy, 1998, 189, Pt 1, 50-56.Applicant
Fujihira, et al., “Effect of capillary force on friction force microscopy: a scanning hydrophilicity microscope” Chemistry Letters, Jul. 1996, 7:499-500.Applicant
Gillen, G., Bennett, J., et al., “Molecular imaging secondary ion mass spectrometry for the characterization of patterned self-assembled monolayers on silver and gold” Anal. Chemistry, 1994, 66:2170-2174.Applicant
Girault, S., Chassaing, G. et al, “Coupling of MALDI-TOF mass analysis to the separation of biotinylated peptides by magnetic streptavidin beads” Anal. Chemistry 1996, 68:2122-2126.Applicant
Grabar, et al., “Preparation and characterization of Au colloid monolayers” Anal. Chem., 1995, 67(4):735-743.Applicant
Haab, et al., “Protein microarrays for highly parallel detection and quantitation of specific proteins and antibodies in complex solutions” Genome Biology, 2001, 2(2)0004.1-0004.13.Applicant
Hansma, H.G., et al., “Atomic force microscopy of long and short double-stranded, single-stranded, and triple-stranded nucleic acids” Nuc. Acids Res., 1996, 24(4):713-720.Applicant
Hansma, H.G., et al., “Recent advances in atomic force microscopy of DNA” Scanning 1993, 15(5):296-9.Applicant
Hansma, H.G., Sinsheimer, R.L., et al., “Atomic force microscopy of single-and double-stranded DNA” Nucleic Acids Research 1992, 20:3585-90.Applicant
Hansma, P.K., et al., “Tapping mode atomic force microscopy in liquids” Appl. Phys. Lett., 1994, 64(13):1738-1740.Applicant
Heller, et al., “Discovery and analysis of inflammatory disease-related genes using cDNA microarrays” PNAS USA, 1997, 94: 2150-2155.Applicant
Henderson, E., “Atomic force microscopy of conventional and unconventional nucleic acid structures” Journal of Microscopy, 1992, 77-84.Applicant
Henderson, E., “Imaging and nanodissection of individual supercoiled plasmids by atomic force microscopy” Nuc. Acids Res., 1992, 20(3):445-447.Applicant
Henderson, E., “Imaging of Living Cells by Atomic Force Microscopy” Progress in Surface Science, May 1994, 46(1):39-60.Applicant
Henderson, E., “Molecular force detection and spectroscopy with the atomic force microscope” Science Progress, 1998, 81(2):141-151.Applicant
Henderson, E., et al., “Actin Filament Dynamics in Living Glial Cells Imaged by Atomic Force Microscopy” Science, 1992, 257:1944-1946.Applicant
Henderson, E., et al., “New Ribosome Structure” Science, 1984, 255:510-512.Applicant
Henderson, E., et al., “Telomeric DNA oligonucleotides form novel intramolecular structures containing guanine-guanine base pairs” Cell, 51(6):899-908.Applicant
Henderson, et al., “A method for gold coating experimental detector beampipes” httb://www.Ins.cornell.edu/public/CBN/1999/CBN99-7/cbn99-7.pdf, 1999.Applicant
Hiller, et al., “Microarrayed allergen molecules: diagnostic gatekeepers for allergy treatment” FASEB, 2002, 16:414-416.Applicant
Hinterdorfer, P. et al., “Detection and localization of individual antibody-antigen recognition events by atomic force microscopy” PNAS, 1996, 93:3477-3481.Applicant
Hoh, J.H. and Hansma, P.K., “Atomic force microscopy for high resolution imaging in cell biology” Trends in Cell Biology, 1992, 2:208-213.Applicant
Hoh, J.H., et al., “Atomic force microscopy and dissection of gap junctions” Science, 1991, 1405-1408.Applicant
Hoh, J.H., et al., “Quantized adhesion detected with the atomic force microscope” J. Am. Chem. Soc., 1992, 114:4917-4918.Applicant
Hong, et al., “A new tool for studying the in situ growth processes for self-assembled monolayers under ambient conditions” Langmuir, 1999, 15:7879-7900.Applicant
Hong, et al., “Multiple ink nanolithography: toward a multiple-pen nano-plotter” Science, 1999, 286:523-525.Applicant
Hong, S. et al. “A Nanoplotter with Both Parallel and Serial Writing Capabilities” Science, Jun. 9, 2000, 288:1808-1811.Applicant
Hovis, et al., “Cyloaddition chemistry and formation of ordered organic monolayers on silicone (001) surfaces” Surface Science, 1998, 402-404, pp. 1-7.Applicant
Hovis, et al., “Structure and bonding of ordered organic monolayers of 1,5-cyclooctadiene on the silicon (001) Surface” J. Phys. Chem. B., 1997, 101:9581-9585.Applicant
Hu, et al., “Imaging the condensation and evaporation of molecularly thin films of water with nanometer resolution” Science, 1995, 268(5208):267-269.Applicant
Huck, et al., “Patterned polymer multilayers as etch resists” Langmuir, 1999, 15:6862-6867.Applicant
Ivanisevic, et al., “Dip-Pen Nanolithography on Semiconductor Surfaces” J. Am. Chem. Soc., 2001, 123:7887-7889.Applicant
Iyer, et al., “The Transcription Program in the Response of Human Fibroblasts to Serum” Science, 1999, 283(5398):83-87.Applicant
Jackman, et al., “Fabrication of submicrometer features on curved substrates by microcontact printing” Science, 1995, 269: 664-666.Applicant
James, et al., “Patterned protein layers on solid substrates by thin stamp microcontact printing” Langmuir, 1998, 14:741-744.Applicant
Janes, et al., “Electronic conduction through 2D arrays of nanometer diameter metal clusters” Superlattices and Microstructures, 1995, 18(4):275-282.Applicant
Jaschke, et al., “Deposition of organic material by the tip of a scanning force microscope” Langmuir, 1995, 11:1061-1064.Applicant
Jin, X., Unertl, W., “Submicrometer modification of polymer surfaces with a surface force microscope” Applied Physics Letters, 1992, 61(6):657-659.Applicant
Jones, V., et al., “Microminiaturized Immunoassays Using Atomic Force Microscopy and Compositionally Patterned Antigen Arrays 66” Anal. Chem., 1998, 70(7):1233-1241.Applicant
Karpovich, et al., “Direct measurement of the adsorption kinetics of alkanethioilate self-assembled monolayers on microcrystalline gold surface” Langmuir, 1994, 10:3315-3322.Applicant
Kim, et al., “Nanotube nanotweezers” Science, Dec. 10, 1999, 286:2148-2150.Applicant
Knezevic et al., “Proteomic profiling of the cancer microenvironment by antibody arrays” Proteomics, 2001,. 1:1271-1278.Applicant
Kochanek, et al., “Transciptional silencing of human ALU sequences and inhibition of protein binding in the box B regulatory elements by 5'CG3 methylation” FEBS Lett., 1995, 360(2):115-120 [PMID 7875314] Abstract.Applicant
Komeda, et al., “Octadecyltrichlorosilane self-assembled-monolayer islands as a self-patterned-mask for HF etching of SiO2 on Si” J. Vac. Sci. Technol A., 1998, 16(3):1680-1685.Applicant
Kumar, et al., “The use of self-assembled monolayers and a selective etch to generate patterned gold features” J. Am. Chem. Soc., 1992, 114:9188-9189.Applicant
Lahiri, et al., “Patterning ligands on reactive SAMs by microcontact printing” Langmuir, 1999, 15:2055-2060.Applicant
Laibinis et al., “ω-terminated alkanethiolate monolayers on surfaces of copper, silver, and gold have similar wettabilities1” J. Am. Chem. Soc., 1992, 114: 1990-1995.Applicant
Lal, R. and John, S.A., “Biological applications of atomic force microscopy” Am J. Physiology, 1994, 266(1):1-21.Applicant
Lanio, T., et al., “PCR-based random mutagenesis method using spiked oligonucleotides to randomize selected parts of gene without any wild-type background” Biotechnique, 1998, 25(6):958-965.Applicant
Lee, et al., “Nanometer-scale lithography on H-passivated Si(100) by atomic force microscope in air” J. Vac. Sci. Technol. A., 1997, 15(3):1451-1454.Applicant
Lee, G. et al., “Direct measurement of the forces between complementary strands of DNA” Science, 1994, 266:771-773.Applicant
Lercel, et al. “Self-assembled monolayer electron-beam resists on GaAs and SiO2” J. Vac. Sci. Technol. B., 1993, 11(6): 2823-2828.Applicant
Lercel, et al., “Sub-10nm lithography with self-assembled monolayers” Appl. Phys. Lett., 1996, 68(11):1504-1506.Applicant
Liu, et al., “Nanofabrication of self-assembled monolayers using scanning probe lithography” Acc. Chem. Res., 2000, 33(7):457-466.Applicant
Lo, et al., “Organic and inorganic contamination on commercial AFM cantilevers” Langmuir, 1999, 15:6522-6526.Applicant
Lüthi, et al., Parallel nanodevice fabrication using a combination of shadow mask and scanning probe methods: Applied Physics Letters, 1999, 75(9):1314-1316.Applicant
Lutwyche, et al., “5X5 2D AFM cantilever arrays a first step toward Terabit storage device” Sensors and Actuators, 1999, 73:89-94.Applicant
Lynch, M., et al., “A Reliable Preparation Method for Imaging DNA by AFM” Microscopy Today, 1999, 99(9) 1 pg.Applicant
Lyubchenko, Y.L., et al., “Atomic force microscopy of DNA and bacteriophage in air, water and propanol: The role of adhesion forces”Nuc. Acids Res., 1993, 21(5):1117-1123.Applicant
Macaya, et al., “Thrombin-binding DNA aptamer forms a unimolecular quadruplex structure in solution” PNAS USA, Apr. 1993, 90:3745-3749.Applicant
MacBeath, G. and Schreiber, S.L., “Printing Proteins as Microarrays for High-Throughput Function Determination” Science, Sep. 8, 2000, 289:1760-1763.Applicant
Magno, R., Bennett, B., “Nanostructure patterns written in III-V semiconductors by an atomic force microscope” Applied Physics Letters, 1997, 70(14):1855-1857.Applicant
Malmborg, et al., “Real Time Analysis of Antibody-Antigen Reaction Kinetics”, Scand. J. Immunol., 1992, 35:634-650.Applicant
Marsh, T.C., et al., “A new DNA nanosctructure imaged by scanning probe microscopy” Nuc. Acids Res. 1995, 23(4):696-700.Applicant
Marsh, T.C., et al., “G-wires: Self-assembly of a telometic oligonucleotide, d(GGGGTTGGGG), into large superstructures” Biochemistry 1994, 33:10718-10724.Applicant
Martin, B., et al., “Ortogonal Self-Assembly on Colloidal Gold-Platinum Nanorods” Advanced Materials, 1999, 11:1021.Applicant
Matteucci, et al., “Synthesis of deoxyoligonucleotides on a polymer support 1” J. Am. Chem. Soc., 1981, 103:3185-3191.Applicant
Maynor, et al., “Au :Ink” for AFM “Dip-Pen” Nanolithography Langmuir, 2001, 17:2575-2579.Applicant
Mazzola, L., “Discrimination of DNA hybridization using chemical force microscopy” Biophysical Journal, 1999, 76:2922-2933.Applicant
Mazzola, L., “Imaging biomolecule arrays by atomic force microscopy” Biophysical Journal, 1995, 68:1653-1660.Applicant
Fuhrer, et al., “Crossed nanotube Junctions” Science, Apr. 21, 2000, 288:494-497.Applicant
Meister, et al., “Nanoscale Dispensing of Liquids through Cantilevered Probes” MNE '02, Lugano, Switzerland, Sep. 16-19, 2002.Applicant
Mendoza, et al., “High-Throughput Microarray-Based Enzyme-Linked Immunosorbent Assay (ELISA)” BioTechniques, 1994, 27(4):778-788.Applicant
Meyer, G. and N.M. Amer, “Novel optical approach to atomic force microscopy” Appl. Phys. Lett., 1988, 53:1045-1047.Applicant
Minne, et al., “Centimeter scale atomic force microscope imaging and lithography” Applied Physics Letters, 1998, 73(12):1742-1744.Applicant
Minne, S.C., et al., “Automated parallel high-speed atomic force microscopy” Appl. Phys. Lett., 1998, 72(18):2340-2342.Applicant
Mirkin, et al., “Dip-Pen Nanolithography: Controlling Surface Architecture on the Sub-100 Nanometer Length Scale” Chemphyschem, 2001, 2:37-39.Applicant
Mirkin, et al., “Programming the Assembly of Two- and Three-Dimensional Architectures with DNA and Nanoscale Inorganic Building Blocks” Invited Contribution from Recipient of ACS Award in Pure Chemistry Inorg. Chem., 2000, 39:2258-2272.Applicant
Mosher, C., et al., “NanoArrays, The Next Generation Molecular Array Format for High Throughput Proteomics, Diagnostics and Drug Recovery” JALA, 2000, 5(5):75-83.Applicant
Moy, et al., “Intermolecular Forces and Energies Between Ligands and Receptors” Science, 1994, 266:257-259.Applicant
Moy, V.T., et al., “Probing the forces between complimentary strands of DNA with the atomic force microscope” SPIE, 1995, 2384:2-12.Applicant
Mueller, et al., “Atomic force microscopy deposition of poly-l-lysine structures onto lipid bilayers supported by mica” Langmuir, 2000, 16:9568-9570.Applicant
Müller, et al., “Nanostructuring of alkanethiols with ultrastrap field emitters” J. Vac. Sci. Technol. B., 1995, 13(6):2846-2849.Applicant
Murray, et al., “Atomic force microscopy of biochemically tagged DNA” Proc., Natl., Acad. Sci., 1993, 90:3811-3814.Applicant
Musil, C., Nanostructuring of gold electrodes for immunosensing applications: J. Vac. Sci. Technol. B., 1995, 13(6):2781-2786.Applicant
Niu, et al., “Atomic force microscopy of DNA-colloidal gold and DNA-protein complexes” SPIE Advances in DNA Sequencing Technology, 1993, 1891:71-77.Applicant
Noy, et al., “Chemical force microscopy: exploiting chemically-modified tips to quantify adhesion, friction, and functional group distributions in molecular assemblies” J. Am. Chem., 1995, 117:7943-7951.Applicant
Noy, et al., “Chemically-sensitive imaging in tapping mode by chemical force microscopy: relationship between phase lag adhesion” Langmuir, 1998, 14:1508-1511.Applicant
Nuzzo, R., “Spontaneously organized molecular assemblies. 3. Preparation and properties of solution adsorbed monolayers of organic disulfides on gold surfaces” J. Am. Chem. Soc., 1987, 109:2358-2368.Applicant
Nyffenegger, et al., “Nonometer scale surface modification using the scanning probe microscope: progress since 1991” Chem. Rev., 1997, 97:1195-1230.Applicant
O'Brien, J., et al., “Immunosensing Platforms Using Spontaneously Absorbed Antibody Fragments on Gold” Analytical Chemistry, 2000, 72(4)703-710 [PMID 10701253] Abstract.Applicant
Oshio, T. et al., “Atomic force microscopy detection system using an optical fiber heterodyne interferometer free from external disturbances” Ultramicroscopy 42-44 (Jul. 1992) 310-314.Applicant
Paweletz, et al., “Reverse phase protein microarrays which capture disease progression shoe activation of pro-survival pathways at the cancer invasion front” Oncogen, 2001, 20:1981-1989.Applicant
Pawlak, et al., “Zeptosens' protein microarrays: A novel high performance microarray platform for low abundance protein analysis” Proteomics, 2002,. 2:383-393.Applicant
Perkins, et al., “Fabrication of 15 nm wide trenches in Si by vacuum scanning tunneling microscope lithography of an organosilane self-assembled film and reactive ion etching” Appl. Phys. Lett., 1996, 68(4):550-552.Applicant
Pfannschmidt, et al., “Sequence-specific labeling of superhelical DNA by triple helix formation and psoralen crosslinking” Nucleic Acids Research, 1996 24(9):1702-1709.Applicant
Piner, et al., “Improved imaging of soft materials with modified AFM tips” Langmuir, 1999, 15:5457-5460.Applicant
Piner, R.D., et al., “Dip-Pen Nanolithography” Science, Jan. 29, 1999,283(5402):661-663.Applicant
Piner, Richard, “Effect of water on lateral force microscopy in air” Langmuir, 1997, 13:6864-6868.Applicant
Putnam, C.A.J., “Tapping atomic force microscopy in liquids” Appl. Phys. Lett., 1994, 64(18):2454-2456.Applicant
Qin, et al., Fabrication of ordered two-dimensional arrays of micro- and nanoparticles using patterned self-assembled monolayers as templates: Adv. Matter, 1999, 11(17):1433-1437.Applicant
Rankin, P.C. Wilson, A.T. “The Surface Chemistry of the Mica-Aluminum-Sulfate System” Journal of Colloid and Interface Science, (1969) 30(3):277-282.Applicant
Reed, et al., “Conductance of molecular junction” Science, 1997, 278:252-254.Applicant
Rief, et al., “Reversible unfolding of individual Titin Ig-domains by AFM” Science, 1997, 276:1109-1111.Applicant
Rief, M., et al., “Single Molecule Force Spectroscopy on Polysaccharides by Atomic Force Microscopy” Science, 1997, 275:1295-1297.Applicant
Rief, M., et al., “The mechanical stability of immunoglobulin and fibronectin III domains in the muscle protein titin measured by atomic force microscopy” Biophysical Journal, 1998, 3008-3014.Applicant
Robinson, et al., Autoantigen microarrays for multiplex characterization of autoantibody responses Nature Medicine, Mar. 2002, 8(3):1-7.Applicant
Santos, et al., “Probing hydrophobic interactions of surfaces and macromolecules with atomic force microscope” Book of Abstracts, 214 ACS National meeting, Sep. 7-11, 1997, PHYS-248.Applicant
Sastry, et al., “Formation of patterned hetrocolloidal nanoparticle thin films” Langmuir, 2000, 16:3553-3556.Applicant
Schaus, S., et al., “Cell Viability and Probe-Cell Membrane Interactions of XR1 Glial Cells Imaged by Atomic Force Microscopy” Biophysical Journal, Sep. 1997, 73:1205-1214.Applicant
Schena, et al., “Parallel human genome analysis: Microarray-based expression monitoring of 1000 genes” PNAS USA, 1996, 93:10614-10619.Applicant
Schoer, et al., “Scanning probe lithography. 4. Characterization of scanning tunneling microscope-induced patterns in n-Alknethiol self-assembled monolayers” Langmuir, 1997, 13:2323-2332.Applicant
Schumacher, et al., “Nanomachining of mesoscopic electronic devices using an atomic force microscope” Applied Physics, 1999, 75(8):1107-1109.Applicant
Schwartz, et al. “Meniscus Force Nanografting: Nanoscopic Patterning of DNA” Langmuir, 2001, 17:5971-5977.Applicant
Schwartz, et al., “Molecular Transport from an Atomic Force Microscope Tip: A Comparative Study of Dip-Pen Nanolithography” Langmuir, American Chemical Society, Nov. 6, 2001.Applicant
Schweitzer, et al., “Multiplexed protein profiling on microarrays by rolling-circle amplification” Nature Biotechnology, Apr. 2002, 20:359-365.Applicant
Shaiu, W.L., et al., “Atomic Force Microscopy of Oriented Linear DNA Molecules Labeled with 5nm Gold Spheres” Nuc. Acids Res., 1993, 21(1):99-103.Applicant
Shaiu, W.L., et al., “Visualization of circular DNA molecules labeled with colloidal gold spheres using atomic force microscopy” J. Vac. Sci. Technol. A., 11(4):820-823.Applicant
Sheehan, et al., “Thiol diffusion and the role of humidity in “dip pen” nanolithography” Physical Review Letters, Apr. 15, 2002, 88(15):156104-1-56104-4.Applicant
Sheen, et al., “A new class of organized self-assembled monolayers: alkane thiols on GaAs (100)” J. Am. Chem. Soc., 1992, 114:1514-1515.Applicant
Sherman, Chemical Vapor Deposition For Microelectornices: Principles, Technology and Applications (Noyes, Park Ridges, NJ, 1987). (Book Reference Not Being Provided).Applicant
Shlyakhtenko, L.S., et al., “Structure and dynamics of supercoil-stabilized DNA cruciforms” J. Mol. Biol., 1998, 280(1):61-72.Applicant
Shlyakhtenko, L.S., Gall, A.A., et al., “Atomic force microscopy imaging of DNA covalently immobilized on a functional mica substrate” Biophysical Journal, Jul. 1999, 77:568-576.Applicant
Silzel, et al., “Mass-sensing, multianalyte microarray immunoassay with imaging detection” Clinical Chemistry, 1998, 44(9):2036-2043.Applicant
Collins, et al., “Nanotube Device” Science, Oct. 3, 1997, 278:100-103.Applicant
Smith et al., “Overstretching B-DNA: the elastic response of individual double-stranded and single stranded DNA molecules” Science, Feb. 9, 1996, 271:795-799.Applicant
Snow, et al., “High speed patterning of a metal silicide using scanned probe lithography” Applied Physics Letters, 1999, 75(10):1476-1478.Applicant
Soh, H., et al., “Integrated nanotube circuits: controlled growth and ohmic contacts to single-walled-carbon nanotubes” Appl. Phys. Lett., 1999, 75(5): 627-629.Applicant
Sondag-Huethorst, et al., “Generation of electrochemically deposited metal patterns by means of electron beam (nano)lithography of self-assembled monolayer resists” Appl. Phys. Lett. 1994, 64(3):285-287.Applicant
Southern, E.M., “Detection of specific sequences among DNA fragments separated by gel electrophoresis” J. Mol. Biol. 1975, 98:503-517.Applicant
Spectroscopy Europe—News Feb./Mar. 2002, 6 pages, http://www.spectroscopyeurope.com/news14_1.html.Applicant
Spence, J., Weierstall, U., et al., “Atomic species identification in scanning tunneling microscopy by time of flight spectroscopy” J. Vac. Sci. Tech., 1996, B14(3):1587-1590.Applicant
Sreekumar, et al., “Profiling of cancer cells using protein microarrays: Discovery of novel radiation-regulated proteins” Cancer Research, 2001, 61:7585-7593.Applicant
Steiner, et al., “Adsorption of alkanenitriles and alkanedinitriles on gold and copper” Langmuir, 1992, 8:2271-2777.Applicant
Stöckle, R., Setz, P. “Nanoscale Atmospheric Pressure Laser Ablation-Mass Spectrometry” Anal. Chem., 2001, 73(7):1399-1402.Applicant
Su, et al., “Moving beyond Molecules: Patterning Solid-State Features via Dip-Pen Nanolithography with Sol-Based Inks” JACS, 2002, 124(8):1560-1561.Applicant
Sun, et al., “Nanoscale Molecular Patterns Fabricated by Using Scanning Near-Field Optical Lithography” JACS, 2002, 124(11):2414-2415.Applicant
Tang, K., Fu, D., et al., “Matrix-assisted laser desorption/ionization mass spectrometry of immobilized duplex DNA probes” Nucleic Acids Research, 1995, 23(16):3126-3131.Applicant
Tans, et al., “Room-temperature transistor based on a single carbon nanotube” Nature, May 7, 1998, 393:49-52.Applicant
Tarlov, M.J., Newman, J.G., et al., “Static secondary ion mass spectrometry of self-assembled alkanethiol monolayers on gold” Langmuir, 1992, 8:1398-1405.Applicant
Tien, et al., “Microfabrication through electrostatic self-assembly” Langmuir, 1997, 13:5349-5355.Applicant
Troughton, E., Bain, C., et al., “Monolayer films prepared by the spontaneous self-assembly of symmetrical and unsymmetrical dialkyl sulfides from solution onto gold substrates: Structure, properties and reactivity of constituent functional groups” Langmuir, 1988, 4:365-385.Applicant
Tsukamoto, et al. “Twin-probe scanning tunneling microscope” Rev. Sci. Instrum., Jul. 1991, 62(7):767-1771.Applicant
Uetz, P., et al., “A comprehensive analysis of protein-protein interactions in Saccharomyces cerevisiae” Nature, Feb. 10, 2000, 403(6770):623-627.Applicant
Ulman, Abraham, “Formation and structure of self-assembled monolayers” Chem. Rev., 1996, 96:1533-1554.Applicant
Vesenka, J. et al., “A substrate preparation for reliable imaging of DNA molecules with the scanning force microscope” Ultramicroscopy, 1992, 42-44:1243-1249.Applicant
Vesenka, J., et al., “Colloidal gold particles as an incompressable atomic force microscope imaging standard for assessing the compressability of biomolecules” Biophys. J., 1993, 65:992-997.Applicant
Vesenka, J., et al., “Combining optical and atomic force microscopy for life sciences research” BioTechniques, 1995, 19(2):240-253.Applicant
Vettiger, et al., “Ultrahigh density, high-data-rate NEMS-based AFM data storage system” Microelectronic Engineering, 1999, 46:11-17.Applicant
Vezenov, Dmitri, “Force titrations and ionization state sensitive imaging of functional groups in aqueous solutions by chemical force microscopy” J. Am. Chem. Soc., 1997, 119:2006-2015.Applicant
Vossmeyer, et al., “Combinatorial approaches toward patterning nanocrystals” Journal of Applied Physics, 1998, 84(7):3664.Applicant
Wadu-Mesthrige, et al., “Fabrication and imaging of nanonmeter-sized protein patterns” Langmuir, 1999, 15:8580-8583.Applicant
Wallraff, et al., “Lithographic imaging techniques for the formation of nanoscopic features” Chem. Rev., 1999, 99:1801-1821.Applicant
Walters, D.A., Hampton, A.D., et al. “Atomic force microscope integrated with a scanning electron microscope for tip fabrication” Applied Physics Letters, Aug. 8, 1994, 65(6):787-789.Applicant
Wang, et al., “Nanometer scale patterning and pattern transfer on amorphous Si, crystalline Si, and SiO2 surfaces using self-assembled monolayers” Appl. Phys. Lett., 1997, 70(12):1593-1595.Applicant
Weierstall, U. Spense, J. “Atom species identification in STM using an Imaging Atom-Probe technique” Surface Science 1998, 398: 267-279.Applicant
Whitesides, et al., “Self-assembled monolayers and lithography” Nanophase Chemistry 1995, 39: 109-122.Applicant
Wilbur, et al., “Scanning force microscopes can image patterned self-assembled monolayers” Langmuir, 1995, 11:825-831.Applicant
Williamson, et al., “G-quarters in biology: Riprise” PNAS USA, Apr. 15, 1993, 90(8):3124-3124.Applicant
Williamson, et al., “Monovalent cation-induced structure of telomeric DNA: The G-quartet model” Cell, 1989, 59(5):871-880.Applicant
Wilson, et al., “Surface organization and nanopatterning of collagen by dip-pen nanolithography” PNAS, Nov. 20, 2001, 98(24):13660-13664.Applicant
Wong, S., et al., “Covalently functionalized nanotubes as nanometre-sized probes in chemistry and biolog” Nature, 1998, 394:52-55.Applicant
Wong, S., et al., “Covalently functionalized single-walled carbon nanotube probe tips for chemical force microscopy” Journal of the American Chemical Society, 1998, 120:8557-8558.Applicant
Wong, S., et al., “Functionalization of carbon nanotube AFM probes using tip-activated gases” Chem Physics Letters, 1999, 306:219-225.Applicant
Xia, et al., “A selective etching solution for use with patterned self-assembled monolayers of alkanethiolates on gold” Chem. Mater., 1995, 7:2332-2337.Applicant
Xia, et al., “Complex optical surfaces formed by replica molding against elastomeric masters” Science, 1996, 273: 347-349.Applicant
Xia, et al., “Pattern transfer: self-assembled monolayers as ultrathin resists” Microelectronic Engineering, 1996, 32:255-268.Applicant
Xia, et al., “Soft lithography” Agnew Chem. Int. Ed., 1998, 37:551-575.Applicant
Xia, et al., “Unconventional methods for fabricating and patterning nanostructures” Chem. Rev., 1999, 99:1823-1848.Applicant
Xu, et al., “Fabrication of nanometer scale patterns within self-assembled monolayers by nanografting” Langmuir, 1999, 15:7244-7251.Applicant
Xu, et al., Nanometer-scale fabrication by simultaneous nanoshaving and molecular self-assembly: Langmuir, 1997, 13:127-129.Applicant
Xu, et al., “Wetting and capillary phenomena of water on mica” J. Phys. Chem. B., 1998, 102:540-548.Applicant
Yan Li, et al., “Electrochemical AFM “Dip-Pen” Nanolithography” J. Am. Chem., Soc. 2001, 123:2105-2106.Applicant
Yan, et al., “Patterning a performed, reactive SAM using microcontact printing” J. Am. Chem. Soc., 1998, 120:6179-6180.Applicant
Yan, et al., “Patterning thin films of poly(ethylene imine) on a reactive SAM using microcontact printing” Langmuir, 1999, 15:1208-1214.Applicant
Ying, et al., “Programmable Delivery of DNA through a Nanopipet” Anal. Chem., 2002, 74:1380-1385.Applicant
Youil, R, Screening for mutations by enzyme mismatch cleavage with T4 endonuclease VII PNAS USA, 1995, 92(1):87-91.Applicant
Zhong, Q., et al., “Fractured polymer/silica fiber surface studied by tapping mode atomic force microscopy” Surf. Sci. Lett., Jan. 3, 1993, 290: L 688-L692.Applicant
Zhu, et al., “Analysis of yeast protein kinases using protein chips” Nature Genetics, 2000, 26:283-289.Applicant
Zhu, et al., “Global Analysis of Protein Activities Using Proteome Chips” Science, Sep. 2001, 293(14):2101-2105.Applicant

Abstract